United States Influenza Vaccines Market Report, Analysis and Forecast to 2025
Table of Contents
1. Executive Summary
2. United States Influenza Vaccines Market Size & Analysis (2013 - 2025)
3. United States Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
3.1 Number of Children Vaccinated with Influenza Vaccines
3.2 Number of Adults Vaccinated with Influenza Vaccines
4. Key Drivers and Inhibitors of the United States Influenza Vaccines Market
4.1 Market Drivers
4.2 Market Inhibitors
5. United States Influenza Vaccines Pricing Trends & Analysis
6. United States Influenza Vaccines Production, Supply, and Allocation (By Companies)
7. United States Influenza Vaccines Distribution & Demand (2010 - 2018)
8. Effectiveness of Influenza Vaccines in United States (2004 – 2018)
9. Rapid Diagnostic Testing for the Management of Influenza
10. Distribution Channel & Technique of Influenza Vaccination in United States
11. United States Influenza Vaccines Reimbursement Policies & Regulatory System
11.1 Reimbursement Policies
11.2 Regulation System
12. Major Deals in United States Influenza Vaccines Market
12.1 Merger & Acquisitions
12.2 Collaboration Deal
12.3 Licensing Agreement
12.4 Exclusive Agreement
12.5 Distribution Agreement
13. Promising Influenza Vaccines in Clinical Development
14. Influenza Vaccines Clinical Trial Insights by Phase, Company & Country
14.1 Year 2018
14.2 Year 2017
15. Key Companies Analysis
15.1 Sanofi Pasteur
15.1.1 Business Overview
15.1.2 Influenza Vaccines Portfolio
15.1.3 Influenza Vaccine Value Sales Analysis
15.1.4 Recent Development
15.2 GlaxoSmithKline (GSK)
15.2.1 Business Overview
15.2.2 Influenza Vaccines Portfolio
15.2.3 Influenza Vaccine Sales Value Analysis
15.2.4 Recent Development
15.3.1 Business Overview
15.3.2 Influenza Vaccines Portfolios
15.3.3 Recent Development
15.4.1 Business Overview
15.4.2 Influenza Vaccines Portfolio
15.4.3 Influenza Vaccine Sales Value Analysis
15.4.4 Recent Development
List of Tables
Table 4–1: BiondVax Pharmaceuticals Ltd. Clinical Trials
Table 5–1: United States Pediatric Influenza Vaccines Price, 2018 – 2019
Table 5–2: United States Adult Influenza Vaccine Price, 2018 – 2019
Table 6–1: United States Influenza Vaccines Production, Supply, and Allocation
Table 7–1: Total Percentage of Influenza Vaccines Released by Week,2017 – 2018
Table 7–2: Total Percentage of Influenza Vaccines Released by Week,2016 – 2017
Table 7–3: Total Percentage of Influenza Vaccines Released by Week,2015 – 2016
Table 7–4: Total Percentage of Influenza Vaccines Released by Week,2014 – 2015
Table 8–1: Adjusted Vaccine Effectiveness Estimates for Influenza Seasons, 2004 – 2018
Table 9–1: Influenza Virus Testing Methods
Table 10–1: Distribution of Influenza Vaccination
Table 11–1: United States Simplified Regulatory Pathway from Preclinical to the Marketing Authorization
Table 12–1: Merger & Acquisitions in Influenza Vaccines Market (Million US$),2003 – 2017
Table 12–2: Collaboration Deal in Influenza Vaccines Market,2007 – 2018
Table 12–3: Licensing Agreement in Influenza Vaccines Market,2007 – 2018
Table 12–4: Exclusive Agreement in Influenza Vaccines Market,2009 – 2016
Table 12–5: Distribution Agreement in Influenza Vaccines Market,2005 – 2016
List of Figures
Figure 2–1: United States Influenza Vaccines Market (Million US$),2013 – 2017
Figure 2–2: United States Influenza Vaccines Market Forecast (Million US$),2018 – 2025
Figure 3–1: United States Total Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2017
Figure 3–2: United States Total Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2018 – 2025
Figure 3–3: United States Number of Children Vaccinated with Influenza Vaccines (Thousand),2013 – 2017
Figure 3–4: United States Number of Children Vaccinated with Influenza Vaccines Forecast (Thousand),2018 – 2025
Figure 3–5: United States Number of Adults Vaccinated with Influenza Vaccines (Thousand),2013 – 2017
Figure 3–6: United States Number of Adults Vaccinated with Influenza Vaccines Forecast (Thousand),2018 – 2025
Figure 7–1: United States Influenza Vaccine Doses Distributed, By Season (Million),2010 – 2018
Figure 10–1: United States Place of Influenza Vaccination for Children and Adults,2017 - 2018
Figure 15–1: Sanofi Pasteur Influenza Vaccines Net Sales Value (Million US$),2013 – 2017
Figure 15–2: Sanofi Pasteur Influenza Vaccines Net Sales Value Forecast (Million US$),2018 – 2025
Figure 15–3: GSK Influenza Vaccines Net Sales Value (Million US$),2013 – 2017
Figure 15–4: GSK Influenza Vaccines Net Sales Value Forecast (Million US$),2018 – 2025
Figure 10–5: AstraZeneca Influenza Vaccines Net Sales Value (Million US$),2011 – 2015
Global Encephalitis Vaccine Market Insights, Forecast to 2025
Published: 17-Jan-2019 Price: US 3900 Onwards Pages: 112
Encephalitis virus is a mosquito-borne Flavivirus and is transmitted via an enzootic cycle from mosquitoes to amplifying vertebrate hosts such as pigs and wading birds.
It can easily be prevented using vaccines. It is the most common cause of encephalitis in Asia-Pacific. Encephalitis virus can easily be transmitted to humans through an infected mosquito bite and occurs primarily in rural agricultural areas.
The global Encephalitis Vaccine market is valued at xx million US$ in 2018......
Global Meningococcal Vaccines Market Research Report 2012-2024
Published: 17-Jan-2019 Price: US 1800 Onwards Pages: 74
The global Meningococcal Vaccines market will reach Volume Million USD in 2017 with CAGR xx% 2019-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:......
Global Meningococcal Conjugate Market Size, Status and Forecast 2019-2025
Published: 15-Jan-2019 Price: US 3900 Onwards Pages: 96
Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease.
In 2018, the global Meningococcal Conjugate market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.......
Global H1N1 Vaccines Market Insights, Forecast to 2025
Published: 09-Jan-2019 Price: US 3900 Onwards Pages: 117
A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
The global H1N1 vaccination market is anticipated to boost in the focus period due to the rising cases of swine flu. Additionally, the rising geriatric population increases the risk of respiratory tract diseases, and immune deficient diseases, thus increasing the risk factor ......
Global and Chinese Meningococcal Vaccines Industry, 2018 Market Research Report
Published: 28-Dec-2018 Price: US 3000 Onwards Pages: 138
The 'Global and Chinese Meningococcal Vaccines Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Meningococcal Vaccines industry with a focus on the Chinese market. The report provides key statistics on the market status of the Meningococcal Vaccines manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industr......
Global Influenza Vaccine Market Insights, Forecast to 2025
Published: 27-Dec-2018 Price: US 3900 Onwards Pages: 111
Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by Influenza viruses. A new version of the vaccine is developed twice a year, as the Influenza virus rapidly changes.
The global Influenza Vaccine market is valued at 3090 million US$ in 2018 and will reach 5270 million US$ by the end of 2025, growing at a CAGR of 6.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Influenza Vaccine marke......
Global Pneumococcal Polysaccharide Vaccine Market Insights, Forecast to 2025
Published: 25-Dec-2018 Price: US 3900 Onwards Pages: 116
Pneumococcal disease is an infection caused by the Streptococcus pneumoniae bacteria, which especially affects infants and children below 5 years of age.
The major factors that contribute to the growth of the pneumococcal polysaccharide vaccine market include increasing prevalence of pneumonia globally, improving healthcare infrastructure, rise in government focus on immunization programs for pneumonia, and development of quality vaccines such as PPSV23.
The global Pneumococcal Po......
Global Encephalitis Vaccination Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
Published: 25-Dec-2018 Price: US 3480 Onwards Pages: 132
Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito's classes. People and many animals may be infection source after infection Encephalitis virus.
Scope of the Report:
This report studies the Encephalitis Vaccination market status and ......
Global and Chinese H1N1 Vaccines Industry, 2018 Market Research Report
Published: 17-Dec-2018 Price: US 3000 Onwards Pages: 135
The 'Global and Chinese H1N1 Vaccines Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global H1N1 Vaccines industry with a focus on the Chinese market. The report provides key statistics on the market status of the H1N1 Vaccines manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition,......
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details - email@example.com
/ +1 888 391 5441 )
- Ad Hoc
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs